Compare TCI & CYRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | TCI | CYRX |
|---|---|---|
| Founded | 1983 | 1999 |
| Country | United States | United States |
| Employees | N/A | 1100 |
| Industry | Real Estate | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 349.1M | 419.3M |
| IPO Year | 1994 | 2008 |
| Metric | TCI | CYRX |
|---|---|---|
| Price | $41.18 | $15.37 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 8 |
| Target Price | N/A | ★ $13.31 |
| AVG Volume (30 Days) | 3.7K | ★ 747.6K |
| Earning Date | 05-11-2026 | 05-04-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 135.29 | ★ 156.22 |
| EPS | ★ 0.02 | N/A |
| Revenue | $49,060,000.00 | ★ $176,177,000.00 |
| Revenue This Year | N/A | $11.06 |
| Revenue Next Year | N/A | $8.45 |
| P/E Ratio | $2,020.50 | ★ N/A |
| Revenue Growth | ★ 4.23 | N/A |
| 52 Week Low | $31.48 | $6.69 |
| 52 Week High | $59.65 | $16.89 |
| Indicator | TCI | CYRX |
|---|---|---|
| Relative Strength Index (RSI) | 46.74 | 48.83 |
| Support Level | $34.92 | $14.51 |
| Resistance Level | $42.02 | $16.76 |
| Average True Range (ATR) | 1.79 | 0.80 |
| MACD | -0.79 | -0.08 |
| Stochastic Oscillator | 37.10 | 40.09 |
Transcontinental Realty Investors Inc is a fully integrated externally managed real estate company. It operates in two business segments: the acquisition, development, ownership and management of multifamily properties; and the acquisition, development, ownership and management of commercial properties; which are office properties. The services for its commercial segment include rental of office space and other tenant services, including parking and storage space rental. The services for its multifamily segment include rental of apartments and other tenant services, including parking and storage space rental. the company derives maximum revenue from Multifamily Segment.
CryoPort Inc is a provider of integrated, temperature-controlled supply chain solutions for the life sciences industry, with a focus on supporting the cell and gene therapy market. The company provides services such as temperature-controlled logistics, biostorage, bioservices, cryopreservation solutions, and cryogenic systems manufacturing. It operates through two reportable segments: Life Sciences Services and Life Sciences Products. It generates the majority of its revenue from the Life Sciences Services segment.